{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T17:35:44Z","timestamp":1770226544460,"version":"3.49.0"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Tumor-induced osteomalacia (TIO) is a rare disorder characterized by hypophosphatemic osteomalacia, mainly caused by benign tumors with excessive secretion of fibroblast growth factor 23 (FGF23) and somatostatin receptor expression. Although complete excision is recommended, reports on treatment strategies for anatomically challenging surgical cases are lacking. We report an unresectable case of FGF23 transmitted tumor in the cervical vertebrae causing myelopathy, which was treated with surgical decompression combined with radionuclide therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 52-year-old woman presented to another hospital with complaints of knee pain. After confirming abnormal tracer uptake at the C7 vertebrae using somatostatin receptor scintigraphy and an elevated serum FGF23 level (&amp;gt;800 pg\/mL), TIO was diagnosed 7 years after the initial presentation. Gait disturbance occurred 10 years after the initial presentation; therefore, the patient was referred to our department. Magnetic resonance imaging revealed a tumor with spinal cord compression and vertebral artery encasement, making complete resection impossible. Gait disturbance improved after spinal decompression with partial resection of the tumor. Peptide receptor radionuclide therapy targeting somatostatin receptors was initiated 2 years after surgery. Serum phosphate levels normalized, and the tumor size remained stable after the initiation of PRRT. Ambulation was maintained without joint pain recurrence at 3 years after surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The current literature on FGF23 transmitted tumors in the cervical spine includes six cases treated with definitive local therapy. This case suggests an alternative option for unresectable FGF23 transmitted tumor in the vertebrae, causing spinal myelopathy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1754565","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T05:34:03Z","timestamp":1770183243000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Spinal decompression and radionuclide therapy for an unresectable FGF23 transmitted tumor causing cervical myelopathy: a case report and literature review"],"prefix":"10.3389","volume":"16","author":[{"given":"Shin","family":"Yokoyama","sequence":"first","affiliation":[{"name":"Department of Orthopedic Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University","place":["Sapporo, Japan"]},{"name":"Department of Musculoskeletal Oncology, NHO Hokkaido Cancer Center","place":["Sapporo, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University","place":["Sapporo, Japan"]},{"name":"Department of Musculoskeletal Oncology, NHO Hokkaido Cancer Center","place":["Sapporo, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Yuno","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kin-ikyo Chuo Hospital","place":["Sapporo, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junki","family":"Takenaka","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging, Graduate School of Medicine, Hokkaido University","place":["Sapporo, Japan"]},{"name":"Department of Nuclear Medicine and Comprehensive Heart Failure Center, University Hospital W\u00fcrzburg","place":["W\u00fcrzburg, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Wakabayashi","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging, Graduate School of Medicine, Hokkaido University","place":["Sapporo, Japan"]},{"name":"Department of Nuclear Medicine, Hokkaido University Hospital","place":["Sapporo, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging, Graduate School of Medicine, Hokkaido University","place":["Sapporo, Japan"]},{"name":"Department of Nuclear Medicine, Hokkaido University Hospital","place":["Sapporo, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Kuwahara","sequence":"additional","affiliation":[{"name":"Department of Pathology, NHO Hokkaido Cancer Center","place":["Sapporo, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatake","family":"Matsuoka","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University","place":["Sapporo, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Onodera","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University","place":["Sapporo, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norimasa","family":"Iwasaki","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University","place":["Sapporo, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Iwata","sequence":"additional","affiliation":[{"name":"Department of Musculoskeletal Oncology, NHO Hokkaido Cancer Center","place":["Sapporo, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s00223-024-01317-x","article-title":"Treatment advances in tumor-induced osteomalacia","volume":"116","author":"Hartley","year":"2025","journal-title":"Calcif Tissue Int"},{"key":"B2","doi-asserted-by":"publisher","first-page":"100413","DOI":"10.1016\/j.jbo.2022.100413","article-title":"Fgf-23 transmitted tumor \u2013 induced hypophosphatemic osteomalacia: A rare case of a young woman with recurrent fractures and review of the literature","volume":"33","author":"Frank","year":"2022","journal-title":"J Bone Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"116064","DOI":"10.1016\/j.bone.2021.116064","article-title":"Challenges in the management of tumor-induced osteomalacia (Tio)","volume":"152","author":"Brandi","year":"2021","journal-title":"Bone"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-020-07342-2","article-title":"Diagnostic efficiency of 68Ga-DOTANOC PET\/CT in patients with suspected tumour-induced osteomalaciaGa","volume":"31","author":"He","year":"2021","journal-title":"Eur Radiol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3642","article-title":"Improving diagnosis of tumor-induced osteomalacia with gallium-68 Dotatate pet\/Ct","volume":"98","author":"Clifton-Bligh","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-018-3971-x","article-title":"Diagnostic performance and impact on patient management of 68Ga-DOTA-TOC PET\/CT for detecting osteomalacia-associated tumoursGa","volume":"45","author":"Paquet","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/diagnostics10010002","article-title":"Detection rate of culprit tumors causing osteomalacia using somatostatin receptor PET\/CT: systematic review and meta-analysis","volume":"10","author":"Meyer","year":"2019","journal-title":"Diagnostics (Basel)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12891-017-1446-z","article-title":"A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia","volume":"18","author":"Arai","year":"2017","journal-title":"BMC Musculoskelet Disord"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2967\/jnmt.116.177873","article-title":"177lu-Dotatate prrt in recurrent skull-base phosphaturic mesenchymal tumor causing osteomalacia: a potential application of prrt beyond neuroendocrine tumors","volume":"44","author":"Basu","year":"2016","journal-title":"J Nucl Med Technol"},{"key":"B10","doi-asserted-by":"crossref","DOI":"10.1159\/000510334","article-title":"Peptide receptor radionuclide therapy for a phosphaturic mesenchymal tumor","volume":"13","author":"H\u00e4fliger","year":"2020","journal-title":"Case Rep Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1530\/EC-19-0341","article-title":"Tumor induced osteomalacia in head and neck region: Single Center experience and systematic review","volume":"8","author":"Shah","year":"2019","journal-title":"Endocr Connect"},{"key":"B12","doi-asserted-by":"publisher","first-page":"5460","DOI":"10.3390\/jcm13185460","article-title":"Challenges in contemporary spine surgery: A comprehensive review of surgical, technological, and patient-specific issues","volume":"13","author":"Mensah","year":"2024","journal-title":"J Clin Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3171\/2010.11.SPINE09750","article-title":"Oncogenic osteomalacia of the cervical spine: A rare case of curative resection and reconstruction","volume":"14","author":"Akhter","year":"2011","journal-title":"J Neurosurg Spine"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00776-014-0540-4","article-title":"Tumor-induced osteomalacia caused by phosphaturic mesenchymal tumor of the cervical spine","volume":"20","author":"Nakamura","year":"2015","journal-title":"J Orthop Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.4103\/0028-3886.271274","article-title":"Tumor-induced osteomalacia due to a phosphaturic mesenchymal tumor in the cervical spine: a case report and literature review","volume":"67","author":"Agarwal","year":"2019","journal-title":"Neurol India"},{"key":"B16","article-title":"Stereotactic body radiation therapy for an unresectable Fgf23-secreting tumor of the cervical spine: A case report and literature review","volume":"8","author":"Hockemeyer","year":"2022","journal-title":"J Radiosurg SBRT"},{"key":"B17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40842-020-00101-8","article-title":"A rare cause of atraumatic fractures: case series of four patients with tumor-induced osteomalacia","volume":"6","author":"Chen","year":"2020","journal-title":"Clin Diabetes Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2017.09.002","article-title":"Tumor-induced osteomalacia","volume":"7","author":"Florenzano","year":"2017","journal-title":"Bone Rep"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","article-title":"Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature","volume":"28","author":"Folpe","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2014.29.2.136","article-title":"Diagnostic modalities for Fgf23-producing tumors in patients with tumor-induced osteomalacia","volume":"29","author":"Fukumoto","year":"2014","journal-title":"Endocrinol Metab (Seoul)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac296","article-title":"Effect of burosumab compared with conventional therapy on Younger vs Older Children with X-linked hypophosphatemia","volume":"107","author":"Ward","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad166","article-title":"Metastatic pheochromocytoma and paraganglioma: somatostatin receptor 2 expression, genetics, and therapeutic responses","volume":"108","author":"Fischer","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"B23","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.1038\/s41598-024-54599-4","article-title":"Somatostatin receptor 2 (Sstr2) expression is associated with better clinical outcome and prognosis in rectal neuroendocrine tumors","volume":"14","author":"Kim","year":"2024","journal-title":"Sci Rep"},{"key":"B24","doi-asserted-by":"publisher","first-page":"917968","DOI":"10.1155\/2015\/917968","article-title":"Somatostatin receptor based imaging and radionuclide therapy","volume":"2015","author":"Xu","year":"2015","journal-title":"BioMed Res Int"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1754565\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T05:34:04Z","timestamp":1770183244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1754565\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":24,"alternative-id":["10.3389\/fonc.2026.1754565"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1754565","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"article-number":"1754565"}}